Chase C. Leavitt

CIK 1777467 · See Remarks · last filed 2026-05-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.3K

Companies

3

Total Filings

17

Lifetime Open-Market Net

$88.8K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MOBI See Remarks 3,000 $45.0K 1 2026-05-11
Oncternal Therapeutics, Inc. (ONCT) Delisted General Counsel/Secretary 84,758 $0.53 $44.6K $38.7K 12 2024-02-15
LCTX General Counsel/Secretary 5,000 $1.27 $6.3K $5.1K 3 2021-03-17

Recent Filings · Page 2 of 2

17 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-01-24 Oncternal Therapeutics, Inc. (ONCT) Delisted Grant (A) $0 EDGAR
2022-01-05 Oncternal Therapeutics, Inc. (ONCT) Delisted Grant (A) +29,867 $0 EDGAR
2021-06-15 Oncternal Therapeutics, Inc. (ONCT) Delisted Buy (P) +1,500 $8.2K EDGAR
2021-03-17 LCTX Grant (A) $0 EDGAR
2020-03-19 LCTX Grant (A) $0 EDGAR
2019-08-15 LCTX Mixed +5,000 $5.1K EDGAR
2019-05-22 Grant (A) $0
Showing 1117 of 17
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.